This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220. This website reflects only the author’s view and the Commission is not responsible for any use that may be made of the information it contains.
Search

World Alzheimer’s Month: Spotlight on Mild Cognitive Impairment and the Role of AI-Mind

People exercising

World Alzheimer’s Month: Spotlight on Mild Cognitive Impairment and the Role of AI-Mind September is World Alzheimer’s Month, a global campaign raising awareness about dementia and related cognitive disorders. This year, the campaign emphasizes the theme “Time to act on dementia, Time to act on Alzheimer’s”, highlighting the urgency of addressing the stigma and misconceptions […]

Negative Opinion on Lecanemab for Early Alzheimer’s Disease

Negative Opinion on Eisai’s Lecanemab for Early Alzheimer’s Disease An application for the marketing authorization of lecanemab, a promising treatment for early-stage Alzheimer’s disease, has faced a setback.  The European Medicines Agency (EMA) has issued a negative opinion on the application, causing significant disappointment among stakeholders and patients alike. Despite its previous approvals in the […]

AI-Mind’s Study Newsletter is Now Available in Five Languages

AI-Mind newsletter announcement no3

AI-Mind’s Third Study Newsletter is Now Available in Five Languages We are excited to announce that the third issue of the AI-Mind project study newsletter is now available in five different languages! This newsletter provides valuable updates on the latest advancements in dementia research and offers insights into the progress of the AI-Mind project. Released […]

AI-Mind project clinical protocol recently published

AI-Mind project clinical protocol recently published AI-Mind kicks off the new year with excellent news. A new publication from the project partners titled: “Intelligent Digital Tools for Screening Brain Connectivity and Estimating Dementia Risk in Mild Cognitive Impairment: The AI-Mind Clinical Study Protocol” was recently published in Frontiers in Neurorobotics. Aligning with the European Commission’s […]

AI-Mind study achieves its recruitment target across four European countries

AI-Mind study achieves its recruitment target across four European countries In a groundbreaking development, the AI-Mind study, launched in January 2022, has successfully reached its recruitment target of 1,000 participants with Mild Cognitive Impairment (MCI) across four European countries (Finland, Italy, Norway and Spain). This marks a significant achievement for the largest study of its […]

AI-Mind Advocates for Timely Detection and Accurate Diagnosis of Alzheimer’s Disease

Eli-Lilly-Alzheimers-Disease-Infographic

AI-Mind Advocates for Timely Detection and Accurate Diagnosis In the ongoing mission to raise awareness about the importance of timely detection and accurate diagnosis of Alzheimer’s disease, the AI-Mind Project continues to make significant strides. Contribution to EU Observer Article  At the 33rd Alzheimer Europe Conference (33AEC) held in Helsinki this October, Ira Hebold Haraldsen, […]

AI-Mind at the 33rd Alzheimer Europe Conference

Unlocking the Future: Can AI Predict Dementia Risk? Join AI-Mind’s Groundbreaking Session at #33AEC! Join us at the 33rd Alzheimer Europe Conference (#33AEC) in Helsinki from 16 to 18 October 2023, themed “New opportunities in dementia care, policy, and research”. This collaborative event between Alzheimer Europe and Muistiliitto (Alzheimer Society of Finland) showcases progress in […]

AI-Mind Empowers Understanding of Alzheimer’s

AI-Mind Empowers Understanding: Session at “Infante Don Juan” Centre for the Elders during World Alzheimer’s Month World Alzheimer’s Month Shines Light on Dementia Awareness Every September, World Alzheimer’s Month, organised by Alzheimer’s Disease International (ADI), aims to challenge stigma and raise global awareness about Alzheimer’s and dementia. Since its inception in 2012, September 21st has […]

AI-Mind Launches Study Newsletter

AI-Mind Launches Study Newsletter AI-Mind is excited to announce the launch of its study newsletter, providing valuable updates on the latest advancements in dementia research. Released every four months, this informative newsletter is designed to keep subscribers updated on the latest advancements in dementia research and the AI-Mind project’s progress. In each issue, readers will […]

AI-Mind continues successful enrolment in its clinical study and its follow-up visits

AI-Mind continues successful enrolment in its clinical study and its follow-up visits The members of the AI-Mind consortium are glad to announce that its study is approaching its enrolment goals, with over three-quarters of recruited participants.   The AI-Mind research study is at the heart of the project and will help collecting invaluable data to […]

Only a few days left till the 5th AI-Mind General Assembly!

Crossing and buildings in Madrid and the AI-Mind logo with the text 5th General Assembly

Only a few days left till the 5th AI-Mind General Assembly! We are delighted to announce that the 5th AI-Mind General Assembly (#AIMindGA) will take place this week from 17-18 November as a hybrid event. Hosted by two project partners – The Complutense University Of Madrid (UCM) and Lurtis Rules S.L. (Lurtis) the 5th #AIMindGA will take place in […]

AI-Mind represented at the 32nd Alzheimer Europe Conference “Building bridges”

Alzheimer Europe conference crowd

AI-Mind represented at the 32nd Alzheimer Europe Conference “Building bridges” The 32nd Alzheimer Europe conference (#32AEC) took place between 17 and 19 October in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries. The hybrid format was offered first time, making attendance at the conference as accessible and inclusive […]

AI-Mind passes the mark of 500 research participants for its clinical study

AI-Mind passes the mark of 500 research participants for its clinical study The AI-Mind consortium recently hit a significant milestone as its clinical study has already included more than half of the research participants needed to fulfil its goal. This clinical study is a key part of the AI-Mind project and will help develop and […]

Power of knowledge! AI-Mind contributes to World Alzheimer’s Month

world map in the background, title World Alzheimer’s Dayand the project logo in the left upper corner

Power of knowledge! AI-Mind contributes to World Alzheimer’s Month September is an exceptional month for Alzheimer’s and dementia associations as well as researchers addressing the challenge of dementia. It is the #WorldAlzMonth! All those involved in the treatment, care and support of people living with dementia come together to raise awareness and challenge the stigma. […]

Poster presentation from the AI-Mind partners at Kuopio Alzheimer Symposium

Conference hall of the Alzheimer Symposium in Kuopio

Poster presentation from the AI-Mind partners at Kuopio Alzheimer Symposium AI-Mind partners from Helsinki University Hospital (HUS) presented a poster  ”A study protocol for AI-Mind: Artificial Intelligence combined with neuropsychological and neuropsychological measures for dementia prevention” at the 9th Kuopio Alzheimer Symposium and 3rd Nordic Memory Clinic Conference. The event took place on August 23-25, 2022 […]

Take care of your brain health! AI-Mind educational campaign

The picture of elderly people running and the text follow treh AI-Mind awarness campaign and learn more about mild cognitive impairment, dementia, risk factors and more.

AI-Mind launches the educational social media campaign Every week more people with mild cognitive impairment (MCI) join the AI-Mind study. But what exactly is MCI and what are the symptoms? Is it the same condition as dementia? What are the types of dementia and what are the risk factors? These and many other questions arise […]

AI-Mind coordinator presenting the project at World Economic Forum 2022

Flags of European countries with mountaing in the background (Davos)

AI-Mind coordinator presenting the project at World Economic Forum 2022 AI-Mind coordinator, Dr. Ira Haraldsen (Oslo University Hospital) has been actively involved in the World Economic Forum (WEF) meetings since February 2021. Participating in the WEF discussions in 2021,  this year Dr. Haraldsen has been invitedby by the advisory council of the Davos Alzheimer’s Collaborative […]

Closing the first year with the in-person meeting – 4th AI-Mind General Assembly

The 4th AI-Mind General Assembly meeting closes the first year of the project duration The 4th AI-Mind General Assembly (GA) meeting was an exceptional event bringing together more than 70 participants, including clinicians, health technology assessment (HTA), artificial intelligence (AI) and ethics experts, researchers, students and specialists from other fields involved in the AI-Mind project. […]

The 4th AI-Mind General Assembly

Coloseum in Rome

The 4th AI-Mind General Assembly meeting closing the first year of the project We are delighted to announce that the AI-Mind meeting will be hosted this week from 4-5 May by two project partners – the Università Cattolica del Sacro Cuore (UCSC) and San Raffaele Roma (IRCCS). The 4th AI-Mind General Assembly meeting planned as […]